487 related articles for article (PubMed ID: 8965601)
1. [Pharmacologic and clinical differentiation of prokinetic drugs].
May B; Greving I
Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
[TBL] [Abstract][Full Text] [Related]
2. [Current role of antidopaminergic drugs in pediatrics].
Cinquetti M; Bonetti P; Bertamini P
Pediatr Med Chir; 2000; 22(1):1-7. PubMed ID: 11387760
[TBL] [Abstract][Full Text] [Related]
3. [Prokinetic drugs in digestive disorders].
Carella G; Marra L
Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
[TBL] [Abstract][Full Text] [Related]
4. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
McCallum RW
Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
[TBL] [Abstract][Full Text] [Related]
5. Review of the current status of prokinetic agents in gastroenterology.
McCallum RW
Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
[No Abstract] [Full Text] [Related]
6. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
Brown CK; Khanderia U
Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
[TBL] [Abstract][Full Text] [Related]
7. Domperidone, a new dopamine antagonist.
Champion MC; Hartnett M; Yen M
CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
[TBL] [Abstract][Full Text] [Related]
8. [Gastroesophageal reflux in the newborn].
Urrusti-Sanz J
Gac Med Mex; 1995; 131(5-6):601-3. PubMed ID: 8768609
[No Abstract] [Full Text] [Related]
9. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
[TBL] [Abstract][Full Text] [Related]
10. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
Halter F; Staub P; Hammer B; Guyot J; Miazza BM
J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
[TBL] [Abstract][Full Text] [Related]
11. Prokinetic agents: a key in the future of gastroenterology.
Reynolds JC
Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178
[TBL] [Abstract][Full Text] [Related]
12. Prokinetic therapy for gastroesophageal reflux disease.
Robinson M
Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
[TBL] [Abstract][Full Text] [Related]
13. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
[TBL] [Abstract][Full Text] [Related]
15. Cisapride--more selective than metoclopramide.
Drug Ther Bull; 1990 Nov; 28(23):89-90. PubMed ID: 2131232
[No Abstract] [Full Text] [Related]
16. Domperidone: a peripherally acting dopamine2-receptor antagonist.
Barone JA
Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
[TBL] [Abstract][Full Text] [Related]
17. [Prokinetics in childhood].
Gottrand F
Arch Pediatr; 2010 Jun; 17(6):737-8. PubMed ID: 20654867
[No Abstract] [Full Text] [Related]
18. The current status of gastric prokinetic drugs.
Schapira M; Henrion J; Heller FR
Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
[TBL] [Abstract][Full Text] [Related]
19. [A drive substance for the motor in digestion. Introduction].
Demling L
Fortschr Med Suppl; 1990; 87():4. PubMed ID: 2351358
[No Abstract] [Full Text] [Related]
20. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
Hatlebakk JG; Berstad A
Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
